162 results
Page 5 of 9
6-K
EX-99.1
1iwe1vea7 4hrdwpvm
12 Nov 20
Current report (foreign)
6:15am
424B5
w4nfxbr74wbwp h47y
23 Oct 20
Prospectus supplement for primary offering
4:40pm
6-K
EX-99.1
7a4irql6p
20 Oct 20
Mereo BioPharma Appoints Christine Fox as Chief Financial Officer and Heidi Petersen as Senior Vice President, Regulatory Affairs
7:12am
6-K
EX-99.1
yv2ci4
19 Oct 20
Current report (foreign)
8:10am
6-K
EX-99.1
ggirulfz8q1ziqh
7 Oct 20
Mereo BioPharma Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission
9:53am
F-3
vaxg qz7mb27e4
6 Oct 20
Shelf registration (foreign)
4:25pm
F-3
EX-1.2
dniw 7mhcmeoi
6 Oct 20
Shelf registration (foreign)
4:25pm
F-6EF
EX-99
age0pu1h8f78t34
6 Oct 20
Automatic registration for ADRs (foreign)
4:10pm
6-K
EX-99.2
rbqh6m581gyag
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
52yb4fs2plp3znbnnmf5
29 Sep 20
Current report (foreign)
7:08am
6-K
EX-99.1
bgk3u6escvgditma55mo
28 Sep 20
Mereo BioPharma Announces Changes to Board of Directors
8:08am
6-K
EX-99.1
8nq pdvstg5e
24 Sep 20
Mereo BioPharma Receives FDA Rare Pediatric Disease Designation for Setrusumab for the Treatment of Osteogenesis Imperfecta
8:48am
6-K
EX-99.1
v6smrdhs8lwxaljp6f
25 Aug 20
Mereo BioPharma Announces Initiation of Placebo-Controlled Phase 1b/2 Clinical Trial with Alvelestat in COVID-19 Respiratory Disease
11:14am
6-K
edp apyh89gkrl1w
3 Aug 20
Current report (foreign)
9:15am
F-3
1pt1 rl7k5d
6 Jul 20
Shelf registration (foreign)
4:58pm
POS AM
fnkot6f2vh
2 Jul 20
Prospectus update (post-effective amendment)
3:57pm
6-K
EX-99.3
qz7e04vzq8
30 Jun 20
Result of Annual General Meeting
4:07pm
6-K
5p8j84a vqg1lb
16 Jun 20
Current report (foreign)
4:13pm